Caplin Point Laboratories’ arm receives EIR for Injectable facility

25 Jul 2019 Evaluate

Caplin Point Laboratories’ wholly owned subsidiary -- Caplin Steriles has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for the recently concluded inspection in June 2019.

USFDA has completed inspection at Caplin Steriles’ Injectable site at Gummidipoondi between June 6 and June 14, 2019. This was the third successful USFDA audit at the plant since 2016. 

Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.

Caplin Point Lab Share Price

1665.70 21.10 (1.28%)
06-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.95
Dr. Reddys Lab 1303.90
Cipla 1321.75
Zydus Lifesciences 912.95
Lupin 2344.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×